SCHEMBL1753700

SCHEMBL1753700

Cc1ccc(N(c2ccccc2)c2cccc3c2ccc2c4cccc(N(c5ccccc5)c5ccc(C)cc5)c4ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.39
C5AR1 P21730 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
APP P05067 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
TSHR P16473 2/20 0.36
LMNA P02545 1/20 0.36
ALOX12 P18054 1/20 0.36
ACHE P22303 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
KEAP1 Q14145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7737380 0.96 CYP2C19 (0.41) CYP2C19C5AR1ALDH1A1KDM4ECYP1A2
SCHEMBL10295955 0.93 CYP2C19 (0.35) CYP2C19C5AR1ALDH1A1KDM4ECYP1A2
SCHEMBL10128593 0.90 CYP2C19 (0.42) CYP2C19ALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL17933061 0.89 GAA (0.35) CYP2C19C5AR1ALDH1A1CYP1A2TSHR
SCHEMBL4885222 0.89 ALDH1A1 (0.43) CYP2C19ALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL1753727 0.88 ALDH1A1 (0.39) CYP2C19ALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL462137 0.88 HPRT1 (0.47) ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1
SCHEMBL15024795 0.87 SIGMAR1 (0.47) CYP2C19C5AR1ALDH1A1CYP1A2L3MBTL1
SCHEMBL2944852 0.87 SIGMAR1 (0.47) CYP2C19C5AR1ALDH1A1CYP1A2L3MBTL1
SCHEMBL2537763 0.86 ALDH1A1 (0.42) CYP2C19C5AR1ALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158835-B2 Fluorene compound and organic electroluminescence device CANON KABUSHIKI KAISHA (JP) 2012-04-17 US disclosed
US-8158835-B2 Fluorene compound and organic electroluminescence device CANON KABUSHIKI KAISHA (JP) 2012-04-17 US disclosed
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2009-08-13 US disclosed
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE AFF1, LEF1, AFF2 CYP2C19 251/4885C5AR1 3896/4885ALDH1A1 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.